Raf kinase inhibitory protein reduces bradykinin receptor desensitization

Resultado de la investigación: Articlerevisión exhaustiva


Inflammatory hyperalgesia represents a nociceptive phenotype that can become persistent in nature through dynamic protein modifications. However, a large gap in knowledge exists concerning how the integration of intracellular signaling molecules coordinates a persistent inflammatory phenotype. Herein, we demonstrate that Raf Kinase Anchoring Protein (RKIP) interrupts a vital canonical desensitization pathway to maintain bradykinin (BK) receptor activation in primary afferent neurons. Biochemical analyses of primary neuronal cultures indicate bradykinin-stimulated PKC phosphorylation of RKIP at Ser153. Furthermore, BK exposure increases G-protein Receptor Kinase 2 (GRK2) binding to RKIP, inhibiting pharmacological desensitization of the BK receptor. Additional studies found that molecular RKIP down-regulation increases BK receptor desensitization in real-time imaging of primary afferent neurons, identifying a key pathway integrator in the desensitization process that controls multiple GRK2-sensitive G-protein coupled receptors. Therefore, RKIP serves as an integral scaffolding protein that inhibits BK receptor desensitization. (Figure presented.).

Idioma originalEnglish (US)
Páginas (desde-hasta)156-165
Número de páginas10
PublicaciónJournal of neurochemistry
EstadoPublished - jul 2022

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience


Profundice en los temas de investigación de 'Raf kinase inhibitory protein reduces bradykinin receptor desensitization'. En conjunto forman una huella única.

Citar esto